Novo Nordisk’s diabetes treatments Tresiba and Ryzodeg have been approved for use in the European Union. The European Commission has granted marketing authorisation for Novo Nordisk’s adult ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first ...

Technology can fail and that means for insulin pump users, backup insulin and knowing how to navigate customer care and technical support is critical.

DiabetesMine explores how long a person with diabetes can live without insulin and how they can prolong life.

Bull or Bear, Seeking Alpha is there Markets change, but our community always has the latest in-depth analysis and powerful stock ratings. New! Get unlimited access to breaking stock news—for free.